Shilpa Grover, MD, MPH
1 clinical trials · Sponsor
◉ Watch Shilpa Grover, MD, MPH
| Record | Firm | Date |
|---|---|---|
| Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial (NCT06841705) | Shilpa Grover, MD, MPH | 2025-07-15 |
Track Shilpa Grover, MD, MPH automatically
Every clearance here is in the API, with alerts when new ones post.